BTIG Maintains Buy on Abbott Laboratories, Raises Price Target to $134

Benzinga Newsdesk www.benzinga.com Positive 82.4%

Neg 0% Neu 0% Pos 82.4%

BTIG analyst Marie Thibault maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $131 to $134.